object
lung
transplant
therapeut
endstag
lung
diseas
surviv
limit
due
bronchiol
obliteran
syndrom
restrict
chronic
lung
allograft
dysfunct
sought
common
denomin
lung
transplant
recipi
analyz
risk
factor
trigger
immun
respons
lead
bronchiol
obliteran
syndrom
collect
blood
patient
underw
lung
transplant
institut
exosom
isol
sera
recipi
risk
factor
chronic
reject
stabl
recipi
exosom
analyz
western
blot
use
antibodi
lung
selfantigen
k
alpha
tubulin
collagenv
costimulatori
molecul
costimulatori
molecul
costimulatori
molecul
transcript
factor
nuclear
factor
kappalightchainenhanc
activ
b
cell
hypoxiainduc
factor
class
ii
major
histocompat
complex
transactiv
proteasom
cr
form
chronic
lung
allograft
dysfunct
clad
remain
obstacl
longterm
allograft
function
clad
current
includ
restrict
airway
diseas
obstruct
form
patholog
call
bronchiol
obliteran
syndrom
bo
roughli
ltx
recipi
ltxr
develop
bo
within
year
ltx
ar
bo
consid
primarili
due
immunolog
insult
transplant
lung
report
signific
correl
bo
de
novo
develop
antibodi
ab
mismatch
donor
human
leukocyt
antigen
hla
donorspecif
antibodi
dsa
ab
lungassoci
selfantigen
sag
k
alpha
tubulin
collagen
v
colv
ltx
addit
primari
graft
dysfunct
pgd
respiratori
viral
infect
rvi
number
ar
episod
thought
increas
risk
develop
bo
mechan
aforement
risk
factor
lead
bo
remain
larg
unclear
hypothes
pgd
ar
dsa
andor
bo
induc
releas
exosom
circul
may
play
role
induc
reject
figur
commun
provid
evid
circul
exosom
origin
transplant
lung
describ
exosom
play
vital
role
activ
perpetu
immun
respons
lead
bo
video
exosom
membran
vesicl
nm
diamet
produc
endocyt
pathway
secret
bodi
fluid
contain
membran
cytosol
protein
molecul
essenti
exosom
biogenesi
exosom
also
cellspecif
compon
includ
protein
messeng
rna
microrna
mirna
figur
exosomespecif
protein
includ
protein
involv
exosom
biogenesi
includ
actin
annexin
tumor
suscept
gene
vesicleassoci
membran
protein
exosom
deriv
cancer
cell
harbor
dicer
trbp
protein
convert
premirna
matur
mirna
lead
silenc
messeng
rna
target
cell
initi
tumor
henc
propos
differenti
express
protein
mirna
cancerderiv
exosom
may
serv
potenti
biomark
report
describ
characterist
exosom
found
bronchoalveolar
lavag
fluid
balf
serum
sampl
ltx
gregson
colleagu
analyz
exosom
rna
collect
balf
follow
ltx
demonstr
exosom
isol
patient
acut
cellular
reject
distinct
molecular
signatur
primarili
involv
immun
activ
video
exosom
lung
trasplant
outcom
circulatori
exosom
lungassoci
antigen
present
primari
graft
dysfunct
develop
donorspecif
antibodi
acut
reject
chronic
reject
therefor
circulatori
exosom
lungassoci
antigen
novel
mechan
induc
immun
respons
lead
reject
graft
lung
transplant
video
avail
http
ab
also
present
electron
microscop
evid
express
lung
sag
surfac
exosom
exosom
isol
stabl
ltxr
contain
lung
sag
result
suggest
exosom
induc
reject
transplant
lung
induc
immun
respons
thu
increas
risk
develop
bo
airway
epitheli
cell
line
aec
develop
laboratori
lung
airway
biopsi
immort
transfect
prsvtag
plasmid
cultur
medium
supplement
bovin
serum
albumin
lglutamin
mm
nonessenti
amino
acid
mm
hepe
mm
sodium
pyruv
mm
penicillin
uml
streptomycin
mgml
previous
describ
aec
cell
cultur
hour
presenc
antihla
hi
pra
dilut
ab
lung
sag
colv
mgml
cell
supernat
collect
hour
exosom
isol
cell
without
treatment
use
control
circul
exosom
ltxr
isol
use
total
exosom
isol
kit
invitrogen
thermo
fisher
scientif
waltham
mass
per
manufactur
protocol
summar
brief
plasma
centrifug
minut
remov
debri
plasma
dilut
phosphatebuff
salin
pb
volum
exosom
precipit
solut
volum
incub
minut
centrifug
minut
room
temperatur
exosom
pellet
dissolv
pb
use
analysi
exosom
cultur
media
isol
use
ultracentrifug
brief
cell
supernat
centrifug
minut
remov
cell
debri
supernat
centrifug
minut
isol
exosom
exosom
pellet
store
c
experi
perform
enzymelink
immunosorb
assay
detect
donor
hla
exosom
describ
logozzi
colleagu
minor
modif
plate
coat
ab
biolegend
san
diego
calif
incub
overnight
c
plate
wash
pb
block
bovin
serum
albumin
pb
block
buffer
incub
exosom
mgml
isol
plasma
ltxr
overnight
c
murin
mab
ad
incub
hour
room
temperatur
follow
secondari
ab
goat
antimous
conjug
horseradish
peroxidas
wash
figur
induct
exosom
may
mechan
develop
chronic
lung
allograft
reject
primari
graft
dysfunct
pgd
respiratori
viral
infect
rvi
donorspecif
antibodi
dsa
antibodi
selfantigen
antisag
trigger
stress
endoplasm
reticulum
releas
exosom
contain
lung
selfantigen
donor
hla
persist
exosom
dsa
antibodi
lung
selfantigen
lead
releas
exosom
activ
immun
respons
may
lead
develop
chronic
reject
bronchiol
obliteran
syndrom
bo
transient
exosom
activ
immun
respons
lead
reject
pb
reaction
develop
chemiluminesc
reagent
milliporesigma
burlington
mass
reaction
stop
n
hcl
optic
densiti
measur
nm
proteasom
use
western
blot
specif
ab
load
control
use
protein
mg
resolv
transfer
polyvinyliden
difluorid
membran
membran
block
block
buffer
specif
primari
ab
correspond
secondari
ab
goat
antirabbit
mous
conjug
horseradish
peroxidas
use
detect
express
protein
enhanc
chemiluminesc
substrat
milliporesigma
use
develop
blot
imag
done
use
odyssey
clx
imag
system
licor
bioscienc
lincoln
neb
band
intens
quantifi
imag
j
softwar
nation
institut
health
bethesda
md
determin
lung
sag
colv
western
blot
rabbit
anticolv
abcam
inc
cambridg
unit
kingdom
mous
santa
cruz
biotechnolog
inc
santa
cruz
calif
ab
use
mhc
class
ii
molecul
detect
western
blot
use
ab
mhc
class
ii
abcam
inc
costimulatori
molecul
detect
use
rabbit
anti
cd
abcam
inc
transcript
factor
nfkb
ciita
identifi
western
blot
use
ab
specif
nfkb
cell
signal
technolog
inc
danver
mass
ciita
abcam
inc
adhes
molecul
icam
vcam
detect
western
blot
use
mous
anti
ab
icam
vcam
biolegend
proteasom
subunit
exosom
detect
use
antimous
subunit
proteasom
santa
cruz
biotechnolog
er
stress
marker
perk
analyz
immunoblot
use
ab
specif
perk
statist
analysi
calcul
graphpad
prism
graphpad
softwar
inc
la
jolla
calif
statist
data
express
mean
ae
standard
deviat
use
ttest
nonparametr
mannwhitney
u
test
detect
statist
signific
p
valu
less
consid
statist
signific
analysi
imag
j
softwar
use
quantifi
optic
densiti
blot
fold
chang
base
experi
versu
control
group
sever
ltx
induc
exosom
transplant
organ
releas
circul
contain
lung
sag
colv
exosom
isol
plasma
ltxr
ltxr
without
pgd
ie
diagnos
accord
intern
societi
heart
lung
transplant
guidelin
result
present
figur
demonstr
exosom
present
circul
specif
marker
although
quantiti
greater
plasma
ltxr
patient
howev
ltxr
diagnos
induc
circul
exosom
lung
sag
colv
illustr
patient
data
semiquantit
analysi
densitometri
shown
figur
b
demonstr
exosom
isol
ltxr
significantli
greater
level
lung
sag
colv
increas
p
increas
p
patient
demonstr
ar
may
also
induc
exosom
transplant
organ
isol
exosom
figur
exosom
releas
composit
follow
lung
transplant
exosom
microvesicl
produc
bud
earli
endosom
microvesicl
either
get
degrad
lysosom
releas
cell
exosom
releas
lung
transplant
contain
lung
selfantigen
collagen
type
vand
k
alpha
tubulin
costimulatori
molecul
exosom
marker
mhc
molecul
adhes
molecul
well
messeng
rna
mrna
microrna
mirna
costimulatori
molecul
costimulatori
molecul
costimulatori
molecul
costimulatori
molecul
mhc
major
histocompat
complex
mirna
microrna
mrna
messeng
rna
ltxr
diagnos
ar
timematch
stabl
ltxr
exosom
specif
marker
present
similar
quantiti
ltxr
reject
repres
patient
data
figur
without
reject
repres
stabl
patient
ltxr
diagnos
ar
demonstr
presenc
lung
sag
colv
figur
figur
b
repres
densitometri
result
ltxr
diagnos
reject
stabl
ltxr
exosom
isol
ltxr
ar
significantli
greater
level
lung
sag
colv
increas
p
increas
p
isol
stabl
ltxr
determin
whether
symptomat
rvi
also
lead
exosom
induct
transplant
organ
analyz
patient
diagnos
symptomat
rvi
stabl
patient
clinic
sign
rvi
shown
previous
group
similar
level
exosom
contain
specif
marker
howev
symptomat
rvi
demonstr
exosom
contain
lung
sag
colv
figur
figur
b
present
result
semiquantit
use
densitometri
patient
symptomat
rvi
stabl
without
rvi
level
exosom
lung
sag
significantli
increas
patient
symptomat
rvi
compar
stabl
patient
increas
lung
sag
colv
p
increas
p
de
novo
develop
ab
dsa
gener
thought
increas
risk
develop
ar
cr
follow
ltx
determin
whether
earli
develop
dsa
follow
ltx
induc
circul
exosom
select
ltxr
develop
dsa
within
month
transplant
ltxr
without
dsa
match
durat
follow
transplant
shown
figur
exosom
isol
ltxr
develop
de
novo
dsa
contain
greater
level
lung
sag
colv
ltxr
without
demonstr
dsa
semiquantit
densitometri
ltxr
dsa
without
dsa
figur
b
demonstr
significantli
greater
level
exosom
contain
lung
sag
ltxr
dsa
without
increas
lung
sag
colv
p
increas
p
determin
whether
bind
ab
hla
lung
sag
induc
exosom
vitro
incub
aec
antihla
antilung
sag
exosom
isol
supernat
overnight
incub
ab
exosom
contain
lung
sag
demonstr
ligat
specif
ab
result
induct
releas
exosom
figur
control
cell
without
addit
antibodi
induc
exosom
contain
lung
selfantigen
supernat
determin
whether
ltxr
diagnos
bo
also
induc
circulatori
exosom
lung
sag
identifi
ltxr
diagnos
bo
per
intern
societi
heart
lung
transplant
guidelin
stabl
timematch
ltxr
circul
exosom
isol
plasma
around
time
diagnosi
purifi
exosom
subject
western
blot
presenc
lung
sag
shown
figur
exosom
isol
ltxr
diagnos
bo
contain
lung
sag
densitometri
analysi
demonstr
significantli
greater
level
exosom
lung
sag
colv
exosom
isol
ltxr
bo
isol
stabl
ltxr
chang
level
colv
p
chang
p
figur
b
exosom
isol
ltxr
pgd
symptomat
rvi
ar
dsa
bo
contain
alloand
lung
sag
also
contain
immunoregulatori
molecul
proinflammatori
transcript
factor
proteasom
stress
marker
circul
exosom
isol
ltxr
ar
bo
stabl
ltxr
analyz
western
blot
use
specif
ab
mhc
class
ii
molecul
costimulatori
molecul
transcript
factor
nfkb
ciita
hifa
proteasom
stress
marker
perk
result
present
tabl
summar
find
name
exosom
aforement
postltx
clinic
condit
contain
alloand
lung
sag
also
import
immunoregulatori
molecul
stress
marker
interest
costimulatori
molecul
notabl
absent
exosom
isol
patient
symptomat
rvi
overal
data
present
tabl
suggest
exosom
present
circul
mani
molecul
necessari
augment
immunogen
lead
clad
risk
factor
associ
clad
includ
pgd
rvi
ar
de
novo
develop
ab
dsa
goal
defin
common
denomin
ltxr
diagnos
pgd
rvi
ar
dsa
trigger
immun
respons
lead
bo
commun
present
unifi
biolog
plausibl
mechanist
link
pgd
rvi
alloimmun
respons
c
figur
antihla
hipra
ab
sag
colv
induc
exosom
lung
sag
exosom
isol
aec
treat
antihla
ab
sag
protein
isol
subject
western
blot
western
blot
data
show
treatment
antihla
ab
sag
induc
releas
exosom
contain
sag
colvand
use
load
control
b
densitometri
analysi
show
signific
increas
colv
express
treatment
hla
antibodi
antibodi
sag
experi
done
twice
hla
human
leukocyt
antigen
colv
collagen
v
costimulatori
molecul
k
alpha
tubulin
ab
antibodi
result
clad
ie
induct
releas
circul
exosom
lung
sag
alloantigen
immunestimulatori
molecul
gregson
colleagu
analyz
exosom
rna
balf
follow
ltx
demonstr
exosom
isol
patient
acut
cellular
reject
distinct
molecular
signatur
primarili
involv
immun
activ
comparison
stabl
ltxr
balf
cell
pellet
exosom
transcriptom
patient
ar
cr
ltx
demonstr
molecular
signatur
primarili
involv
innat
adapt
cytotox
immun
respons
recent
demonstr
exosom
isol
sera
balf
ltxr
diagnos
ar
cr
contain
dsa
also
lung
sag
colv
result
suggest
exosom
induc
reject
transplant
lung
induc
immun
respons
therebi
increas
risk
develop
bo
heart
skin
transplant
model
mice
shown
donorderiv
exosom
contain
donor
mhc
crossdress
recipi
antigenpres
cell
lead
activ
prolifer
alloreact
cell
via
semidirect
pathway
allorecognit
previou
studi
laboratori
shown
ab
hla
andor
tissuerestrict
sag
develop
month
lung
allograft
reject
suggest
pathogen
role
ab
develop
bo
follow
ltx
furthermor
patient
develop
either
ab
hla
ab
lung
sag
greater
chanc
develop
ab
suggest
spread
immun
respons
result
clad
howev
mechan
lead
spread
unclear
hla
molecul
lung
sag
encod
differ
gene
differ
chromosom
result
present
studi
murin
model
strongli
support
import
role
exosom
induc
spread
immun
respons
lead
clad
studi
demonstr
increas
express
colv
circul
exosom
isol
ltxr
develop
pgd
rvi
ar
dsa
bo
exosom
also
contain
mhc
class
ii
molecul
transcript
factor
ciita
proinflammatori
transcript
factor
nfkb
hifa
proteosom
furthermor
exosom
ltxr
ar
bo
contain
costimulatori
molecul
support
theori
exosom
highli
immunogen
import
role
proteasom
augment
immun
respons
exosom
recent
present
dieud
colleagu
show
humor
immun
respons
mice
kidney
sag
perlecan
induc
presenc
proteasom
within
exosom
remov
activ
proteasom
abrog
immun
respons
perlecan
demonstr
mice
immun
exosom
isol
ltxr
diagnos
bo
induc
develop
humor
cellular
immun
respons
colv
stabl
patient
addit
distinct
differ
note
exosom
bo
stabl
ltxr
respect
immunogen
use
syngen
cardiac
transplant
model
sharma
colleagu
demonstr
ab
cardiac
myosin
administ
immedi
follow
syngen
murin
heterotop
cardiac
transplant
result
graft
failur
releas
exosom
contain
cardiac
myosin
vimentin
studi
demonstr
import
role
exosom
graft
failur
immun
exosom
isol
sera
follow
graft
failur
also
develop
ab
cardiac
myosin
vimentin
result
graft
loss
day
syngen
cardiac
transplant
follow
human
renal
transplant
evid
releas
increas
level
circul
plasma
endotheli
microvesicl
correl
antibodymedi
ar
indic
ab
develop
de
novo
induc
exosom
may
particip
antibodymedi
reject
one
major
limit
studi
rel
small
number
patient
analyz
clinic
condit
analyz
variou
sub
categori
futur
studi
need
exosom
isol
differ
grade
pgd
ar
well
bo
conclus
result
demonstr
circul
exosom
induc
easili
isol
ltxr
diagnos
pgd
rvi
ar
dsa
bo
circul
exosom
distinct
properti
compar
stabl
ltxr
respect
presenc
tissueassoci
lung
sag
colv
costimulatori
molecul
mhc
class
ii
transcript
factor
ciita
proinflammatori
transcript
factor
includ
nfkb
hifa
proteasom
propos
induct
circul
exosom
import
unifi
mechanist
link
pgd
rvi
alloimmun
respons
increas
risk
develop
clad
follow
ltx
author
noth
disclos
regard
commerci
support
thank
clare
sonntag
billi
glasscock
assist
submit
paper
